Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (Journal of Neurology, (2022), 269, 10, (5382-5394), 10.1007/s00415-022-11193-w)

Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa, Maria Trojano

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (Journal of Neurology, (2022), 269, 10, (5382-5394), 10.1007/s00415-022-11193-w)'. Together they form a unique fingerprint.

Medicine & Life Sciences